Matthew Deady
1
, BA ;
Raymond Duncan
2
, BA, MD ;
Matthew Sonesen
3
, BA ;
Renier Estiandan
3
, BA ;
Kelly Stimpert
4
, BA ;
Sylvia Cho
5
, PhD, MHS ;
Jeffrey Beers
1
, MD ;
Brian Goodness
1
, MA ;
Lance Daniel Jones
1
, BA, MA ;
Richard Forshee
5
, PhD ;
Steven A Anderson
5
, PhD ;
Hussein Ezzeldin
5
, PhD
1
IBM Consulting, Bethesda, MD, United States
2
Departments of Enterprise Information Services and Pediatrics, Cedars-Sinai Health System, Los Angeles, CA, United States
3
Cedars-Sinai Health System, Enterprise Information Services, Los Angeles, CA, United States
4
DRT Strategies, Inc., Arlington, VA, United States
5
Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, United States
Corresponding Author:
-
Hussein Ezzeldin, PhD
-
Center for Biologics Evaluation and Research
-
Food and Drug Administration
-
10903 New Hampshire Ave
-
Silver Spring, MD, 20993
-
United States
-
Phone:
1 240 205 2215
-
Email: hussein.ezzeldin@fda.hhs.gov